Bernhard Gentner

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

Banca Nazionale del Lavoro SpA provides banking and financial services to households, enterprises, and public sector organizations. Its products include customer, certificate, medium and long-term, and other deposits from banks and customers. The bank also offers loans including short, medium, and long-term financing; mortgage and finance lease. It provides financial intermediary services including factoring, leasing, consumer credit, and equity investment. The company was founded on August 15, 1913 and is headquartered in Rome, Italy.

Esselunga SpA engages in the management of a network of large-scale retail stores. The firm operates supermarkets in the regions of Lombardy, Tuscany, Emilia Romagna, Piedmont, Veneto, Liguria and Lazio. Its stores offer grocery and drugstore items such as cosmetics, household products, health drinks, food items and other related products. The company was founded by Bernardo Caprotti in 1957 and is headquartered in Limito di Pioltello, Italy.

Marazzi Group SRL engages in the design, manufacture, and sale of ceramic tile products. It offers interior and exterior wall, ventilated facade, and raised floor systems. Its products carry the brands which include Treverkmust, Powder, Absolute White, Stone_Art, Chalk, Memento, Poudre, Bricco, Neutral, Chroma, Color Code, Treverkmore, Pottery, Treverkfusion, SistemP, Plaster, Plaster 20mm, Elegance, Cottotoscana20, and Essenziale. The company was founded by Filippo Marazzi in 1935 and is headquartered in Sassuolo, Italy.

Coesia SpA provides industrial and packaging solutions. It offers automated machinery and packaging materials, industrial process solutions, and precision gears. The firm also provides maintenance, equipment modernization, training and documentation, consultancy, and production support services. The company was founded in 1923 and is headquartered in Bologna, Italy.

Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy.

Axon Partners Group Investment SGEIC SA (Axon Partners Group) is a private equity and venture capital firm founded in 2006 by Julio Villalobos Rius. The firm is headquartered in Madrid, Spain with offices across the globe.

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The company is based in Haarlem, Netherlands.

Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU.

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy.

Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy.

Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway.

Istituto Italiano di Tecnologia engages in the scientific research for technological development. It offers mechanical workshop that carries out advisory, construction, design, prototyping, and development activities. Its research domains include robotics, nanomaterials, technologies for life sciences (lifetech), and computational sciences. The company was founded by Giulio Tremonti and Vittorio Grilli in 2003 and is headquartered in Genoa, Italy.

Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani.

Pianoforte Holding SpA engages in the manufacture and distribution of leather goods and fashion apparel and accessories. It offers bags, shoes, underwear, beachwear, sunglasses, and cosmetics under the brand names Carpisa, Yamamay, and Jaked. The company was founded in 2011 and is headquartered in Milan, Italy.

Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.

Digitail SRL provides software solutions for electronic commerce. It develops the mobile application brand EasyCoop which enables online ordering of grocery items for delivery. The company was founded by Marco Di Falco in 2016 and is headquartered in Castenaso, Italy.

Altheia Science Srl develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes. The company was founded by Paolo Fiorina, Alessandra Biffi, Paolo Rizzardi, and is headquartered in Milan, Italy.

Aurora-TT Srl (AuroraTT) is an independent venture capital firm.. Guido Guidi, Gabriele Campi, Pierluigi Paracchi, Gian Paolo Maria Rizzardi and Edoardo Negroni founded the firm in 2017. The firm is headquartered in Milan, Italy.

GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy.

Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy.

Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million.

Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020.